After facing fierce backlash, drugmaker Mylan last week agreed to offer discounts to patients who use its EpiPens. "As a mother, I can assure you, the last thing that we would ever want is no one to ...

WASHINGTON (AP) — The head of the pharmaceutical company Mylan will face lawmakers’ questions at a hearing next week on steep price increases for its life-saving EpiPen injector device. Mylan CEO ...

Mylan beat Sanofi's anti-competitive claims U.S. judge in Kansas weighing dispute June 29 (Reuters) - Drugmaker Sanofi (SASY.PA), opens new tab asked a U.S. judge on Wednesday to curb Mylan's bid to ...

The maker of EpiPens will begin selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues -- and looming competition threatens its ...

WASHINGTON – The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from ...

(Reuters) - Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, ...

Mylan’s $465 million proposed settlement with CMS may not cover the amount of money it allegedly saved by improperly classifying EpiPens as a generic drug, according to research published Monday in ...

Three EpiPen purchasers have filed a class-action lawsuit against Mylan claiming the drug company engaged in an illegal organized scheme to systematically increase EpiPen prices by 574 percent, ...

While Mylan agreed to pay $465 million to resolve accusations it improperly classified EpiPens as a generic drug, the Canonsburg, Pa.-based drugmaker has yet to finalize the settlement with the ...

The company's CEO will defend her company's increase in EpiPen pricing. — -- Mylan Pharmaceuticals CEO Heather Bresch is expected to defend her company’s increase in EpiPen pricing when she ...

WASHINGTON — Despite a withering 4-plus hours of questioning by members of a congressional committee yesterday, Mylan CEO Heather Bresch did not give a direct answer as to why the company had ...

June 29 (Reuters) - Drugmaker Sanofi SASY.PA asked a U.S. judge on Wednesday to curb Mylan's bid to recover litigation costs in an antitrust lawsuit, calling the rival pharmaceutical company's court ...